Skip to the page

Data / Drug companies / Teva Pharmaceuticals USA, Inc.

Teva Pharmaceuticals USA, Inc.: 65 products in the FDA NDC directory, labeler code 0555

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Teva Pharmaceuticals USA, Inc. (labeler code 0555) lists 65 products in the FDA National Drug Code Directory, covering 25 finished drugs by generic name. By type: 62 prescription drugs, 3 drugs for further processing. Its main marketing category is generic drugs (ANDA). The newest product started marketing on May 24, 2023.

The request: Watch Teva Pharmaceuticals USA, Inc. (FDA labeler code 0555): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
0555
Products in commercial distribution
65
Packages
83
Finished drugs by generic name
25
Prescription products
62
Over the counter products
0
Controlled substance products
Schedule II 9, Schedule IV 3
Flagged as original packager
61 of 61 products that carry the flag
Started marketing in the last 12 months
0
Products with a marketing end date set
3
Earliest marketing start
September 1, 1972
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)6193.8%
Drugs for further processing34.6%
Authorized generics (NDA)11.5%

Products by type

TypeProductsShare
Prescription drugs6295.4%
Drugs for further processing34.6%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet3249.2%
Kit1929.2%
Capsule1015.4%
Capsule, liquid filled46.2%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Amiloride hydrochloride and hydrochlorothiazide0555-0483TabletDrugs for further processingMay 24, 2023
Trazodone Hydrochloride0555-0711TabletGeneric drugs (ANDA)December 9, 2021
Leucovorin calcium0555-0485TabletDrugs for further processingJune 10, 2021
Leucovorin calcium0555-0484TabletDrugs for further processingJune 10, 2021
Tri-Legest Fe 28 Day0555-9032KitGeneric drugs (ANDA)October 26, 2007
Balziva0555-9034KitGeneric drugs (ANDA)October 16, 2006
Claravis0555-1056Capsule, liquid filledGeneric drugs (ANDA)May 18, 2006
Kelnor 1/350555-9064KitGeneric drugs (ANDA)June 20, 2005
Aranelle0555-9066KitGeneric drugs (ANDA)October 4, 2004
Velivet Triphasic Regimen0555-9051KitGeneric drugs (ANDA)March 1, 2004
Mefloquine Hydrochloride0555-0171TabletGeneric drugs (ANDA)January 6, 2004
Tri-Sprintec0555-9018KitGeneric drugs (ANDA)December 29, 2003
Jolessa0555-9123KitAuthorized generics (NDA)October 13, 2003
Junel Fe 28 Day0555-9028KitGeneric drugs (ANDA)September 18, 2003
Junel 21 Day0555-9027TabletGeneric drugs (ANDA)September 18, 2003
Junel Fe 28 Day0555-9026KitGeneric drugs (ANDA)September 18, 2003
Junel 21 Day0555-9025TabletGeneric drugs (ANDA)September 18, 2003
Claravis0555-1057Capsule, liquid filledGeneric drugs (ANDA)May 9, 2003
Claravis0555-1055Capsule, liquid filledGeneric drugs (ANDA)May 9, 2003
Claravis0555-1054Capsule, liquid filledGeneric drugs (ANDA)May 9, 2003
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate0555-0777TabletGeneric drugs (ANDA)March 19, 2003
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate0555-0776TabletGeneric drugs (ANDA)March 19, 2003
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate0555-0775TabletGeneric drugs (ANDA)March 19, 2003
Nortrel 7/7/7 (28 Day Regimen)0555-9012KitGeneric drugs (ANDA)January 2, 2003
Sprintec0555-9016KitGeneric drugs (ANDA)September 26, 2002

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.